Bioxcel Therapeutics earnings were -$59.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BTAI earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$10.9M, down 20.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BTAI reported annual earnings of -$59.6M, with -66.7% growth. The next BTAI earnings date is May 7, 2025.
Bioxcel Therapeutics Earnings Reports & History FAQ
What were Bioxcel Therapeutics's earnings last quarter?
On BTAI's earnings call on Invalid Date, Bioxcel Therapeutics (NASDAQ: BTAI) reported Q4 2024 earnings per share (EPS) of -$2.87, up 75.94% year over year. Total BTAI earnings for the quarter were -$10.86 million. In the same quarter last year, Bioxcel Therapeutics's earnings per share (EPS) was -$11.93.
The next BTAI earnings call is Invalid Date. Add BTAI to your watchlist to be reminded of Bioxcel Therapeutics's next earnings date.
What was BTAI's earnings growth in the past year?
As of Bioxcel Therapeutics's earnings date in Invalid Date, Bioxcel Therapeutics's earnings has grown year over year. BTAI earnings in the past year totalled -$59.60 million.
Is Bioxcel Therapeutics profitable or losing money?
As of the last Bioxcel Therapeutics earnings report, Bioxcel Therapeutics is currently losing money. Bioxcel Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$59.60 million, a 66.71% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.